Quantitative versus qualitative data: The numerical dimensions of drug action

David B. Bylund, Myron Lee Toews

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

The application of detailed quantitative analyses of the concentration dependence of the biological responses mediated by endogenous hormones and other mediators, drugs, and related compounds has been the foundation of pharmacology for the past century or more. This approach has been remarkably successful in identifying the specific molecular targets for these mediators and drugs, in establishing the mechanisms for those effects at both the cellular and whole organismal levels, and in the development of new chemical entities (NCEs) with great selectivity for individual molecular targets. The availability of such compounds has unfortunately led to a mindset that detailed quantitative analyses are no longer necessary to use such compounds in understanding biological system function and to draw valid conclusions in regard to the utility of NCEs selective for putative drug targets in the potential treatment of human disease states. This lack of appreciation for quantitative approaches has contributed significantly to the all-too-frequent failures of new drug candidates in early-stage clinical trials. The present article reviews basic drug/receptor concepts together with the mathematical relationships that underlie the quantitative analysis of dose-response and concentration-effect relationships for individual compounds and for more complex systems, such as the comparative analysis of multiple compounds at a single receptor. A thorough understanding of these concepts and their associated analyses, along with their proper and rigorous application in all pre-clinical drug development studies, is an essential component of an integrated approach toward improving drug development.

Original languageEnglish (US)
Pages (from-to)25-39
Number of pages15
JournalBiochemical Pharmacology
Volume87
Issue number1
DOIs
StatePublished - Jan 1 2014

Fingerprint

Pharmaceutical Preparations
Drug Receptors
Biological systems
Large scale systems
Clinical Trials
Availability
Hormones
Pharmacology
Chemical analysis

Keywords

  • Concentration-effect
  • Dose-response
  • Drug action
  • Efficacy
  • Potency

ASJC Scopus subject areas

  • Biochemistry
  • Pharmacology

Cite this

Quantitative versus qualitative data : The numerical dimensions of drug action. / Bylund, David B.; Toews, Myron Lee.

In: Biochemical Pharmacology, Vol. 87, No. 1, 01.01.2014, p. 25-39.

Research output: Contribution to journalArticle

@article{b42c0fbfa3314d38a4c7aeefad0ac46a,
title = "Quantitative versus qualitative data: The numerical dimensions of drug action",
abstract = "The application of detailed quantitative analyses of the concentration dependence of the biological responses mediated by endogenous hormones and other mediators, drugs, and related compounds has been the foundation of pharmacology for the past century or more. This approach has been remarkably successful in identifying the specific molecular targets for these mediators and drugs, in establishing the mechanisms for those effects at both the cellular and whole organismal levels, and in the development of new chemical entities (NCEs) with great selectivity for individual molecular targets. The availability of such compounds has unfortunately led to a mindset that detailed quantitative analyses are no longer necessary to use such compounds in understanding biological system function and to draw valid conclusions in regard to the utility of NCEs selective for putative drug targets in the potential treatment of human disease states. This lack of appreciation for quantitative approaches has contributed significantly to the all-too-frequent failures of new drug candidates in early-stage clinical trials. The present article reviews basic drug/receptor concepts together with the mathematical relationships that underlie the quantitative analysis of dose-response and concentration-effect relationships for individual compounds and for more complex systems, such as the comparative analysis of multiple compounds at a single receptor. A thorough understanding of these concepts and their associated analyses, along with their proper and rigorous application in all pre-clinical drug development studies, is an essential component of an integrated approach toward improving drug development.",
keywords = "Concentration-effect, Dose-response, Drug action, Efficacy, Potency",
author = "Bylund, {David B.} and Toews, {Myron Lee}",
year = "2014",
month = "1",
day = "1",
doi = "10.1016/j.bcp.2013.07.027",
language = "English (US)",
volume = "87",
pages = "25--39",
journal = "Biochemical Pharmacology",
issn = "0006-2952",
publisher = "Elsevier Inc.",
number = "1",

}

TY - JOUR

T1 - Quantitative versus qualitative data

T2 - The numerical dimensions of drug action

AU - Bylund, David B.

AU - Toews, Myron Lee

PY - 2014/1/1

Y1 - 2014/1/1

N2 - The application of detailed quantitative analyses of the concentration dependence of the biological responses mediated by endogenous hormones and other mediators, drugs, and related compounds has been the foundation of pharmacology for the past century or more. This approach has been remarkably successful in identifying the specific molecular targets for these mediators and drugs, in establishing the mechanisms for those effects at both the cellular and whole organismal levels, and in the development of new chemical entities (NCEs) with great selectivity for individual molecular targets. The availability of such compounds has unfortunately led to a mindset that detailed quantitative analyses are no longer necessary to use such compounds in understanding biological system function and to draw valid conclusions in regard to the utility of NCEs selective for putative drug targets in the potential treatment of human disease states. This lack of appreciation for quantitative approaches has contributed significantly to the all-too-frequent failures of new drug candidates in early-stage clinical trials. The present article reviews basic drug/receptor concepts together with the mathematical relationships that underlie the quantitative analysis of dose-response and concentration-effect relationships for individual compounds and for more complex systems, such as the comparative analysis of multiple compounds at a single receptor. A thorough understanding of these concepts and their associated analyses, along with their proper and rigorous application in all pre-clinical drug development studies, is an essential component of an integrated approach toward improving drug development.

AB - The application of detailed quantitative analyses of the concentration dependence of the biological responses mediated by endogenous hormones and other mediators, drugs, and related compounds has been the foundation of pharmacology for the past century or more. This approach has been remarkably successful in identifying the specific molecular targets for these mediators and drugs, in establishing the mechanisms for those effects at both the cellular and whole organismal levels, and in the development of new chemical entities (NCEs) with great selectivity for individual molecular targets. The availability of such compounds has unfortunately led to a mindset that detailed quantitative analyses are no longer necessary to use such compounds in understanding biological system function and to draw valid conclusions in regard to the utility of NCEs selective for putative drug targets in the potential treatment of human disease states. This lack of appreciation for quantitative approaches has contributed significantly to the all-too-frequent failures of new drug candidates in early-stage clinical trials. The present article reviews basic drug/receptor concepts together with the mathematical relationships that underlie the quantitative analysis of dose-response and concentration-effect relationships for individual compounds and for more complex systems, such as the comparative analysis of multiple compounds at a single receptor. A thorough understanding of these concepts and their associated analyses, along with their proper and rigorous application in all pre-clinical drug development studies, is an essential component of an integrated approach toward improving drug development.

KW - Concentration-effect

KW - Dose-response

KW - Drug action

KW - Efficacy

KW - Potency

UR - http://www.scopus.com/inward/record.url?scp=84892364422&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84892364422&partnerID=8YFLogxK

U2 - 10.1016/j.bcp.2013.07.027

DO - 10.1016/j.bcp.2013.07.027

M3 - Article

C2 - 23933389

AN - SCOPUS:84892364422

VL - 87

SP - 25

EP - 39

JO - Biochemical Pharmacology

JF - Biochemical Pharmacology

SN - 0006-2952

IS - 1

ER -